Back
Seres Therapeutics Stock Price Chart
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Sell
25
MCRB
Seres Therapeutics
Last Price:
0.58
Seasonality Move:
-13.92%
7 Day Trial
ALL ACCESS PASS
$
7
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MCRB is experiencing selling pressure, which indicates risk of future bearish movement.
Seres Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.72 | Sell |
| 20-day SMA: | 0.76 | Sell |
| 50-day SMA: | 0.86 | Sell |
| 200-day SMA: | 0.92 | Sell |
| 8-day EMA: | 0.7 | Sell |
| 20-day EMA: | 0.75 | Sell |
| 50-day EMA: | 0.82 | Sell |
| 200-day EMA: | 1.16 | Sell |
Seres Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 27.93 | Sell |
| Chaikin Money Flow: | -5154121 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.7 - 0.82) | Sell |
| Bollinger Bands (100): | (0.74 - 1.12) | Sell |
Seres Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Seres Therapeutics Stock
Is Seres Therapeutics Stock a Buy?
- Seres Therapeutics share price is 0.59 while MCRB 8-day simple moving average is 0.72, which is a Sell signal.
- The stock price of MCRB is 0.59 while Seres Therapeutics 20-day SMA is 0.76, which makes it a Sell.
- Seres Therapeutics 50-day simple moving average is 0.86 while MCRB share price is 0.59, making it a Sell technically.
- MCRB stock price is 0.59 and Seres Therapeutics 200-day simple moving average is 0.92, creating a Sell signal.
MCRB Technical Analysis vs Fundamental Analysis
Sell
25
Seres Therapeutics (MCRB)
is a Sell
Is Seres Therapeutics a Buy or a Sell?
-
Seres Therapeutics stock is rated a Sell
The current Seres Therapeutics [MCRB] share price is $0.59. The Score for MCRB is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Seres Therapeutics Stock Info
Market Cap:
89.55M
Price in USD:
0.59
Share Volume:
5.38M
Seres Therapeutics 52-Week Range
52-Week High:
2.05
52-Week Low:
0.54
Sell
25
Seres Therapeutics (MCRB)
is a Sell
Seres Therapeutics Share Price Forecast
-
What is the Seres Therapeutics stock price today?
The Seres Therapeutics stock price is 0.59 USD today. -
Will MCRB stock go up or go down?
Seres Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Seres Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Seres Therapeutics is overvalued.
Is Seres Therapeutics Stock a Buy?
- Seres Therapeutics share price is 0.59 while MCRB 8-day exponential moving average is 0.70, which is a Sell signal.
- The stock price of MCRB is 0.59 while Seres Therapeutics 20-day EMA is 0.75, which makes it a Sell.
- Seres Therapeutics 50-day exponential moving average is 0.82 while MCRB share price is 0.59, making it a Sell technically.
- MCRB stock price is 0.59 and Seres Therapeutics 200-day simple moving average is 1.16, creating a Sell signal.
Fundamental Analysis of Seres Therapeutics
Is Seres Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and an increase next year of $0.18 per share.
Technical Analysis of Seres Therapeutics
Should I short Seres Therapeutics stock?
- MCRB Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting Seres Therapeutics is a Sell
- Seres Therapeutics Relative Strength Index (RSI) is 27.93, which suggest Seres Therapeutics is oversold
- The Bollinger Bands (25) for Seres Therapeutics is (0.7 - 0.82), which suggest Seres Therapeutics is a Sell
- The Bollinger Bands (100) for Seres Therapeutics is (0.74 - 1.12), which suggest Seres Therapeutics is a Sell
* Seres Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.